2017 - Fellow of the American Association for the Advancement of Science (AAAS)
Virology, Virus, Immunology, Viral replication and Drug resistance are her primary areas of study. Her Virology study combines topics in areas such as Mutation and Mutant. Her Immunology research is multidisciplinary, relying on both Chemotherapy and Genotype.
Her Viral disease research includes themes of Viremia and Acquired immunodeficiency syndrome. Her Acquired immunodeficiency syndrome study integrates concerns from other disciplines, such as Regimen and Gynecology. Her studies in Pediatrics integrate themes in fields like Pre-exposure prophylaxis and Emtricitabine.
Her primary areas of investigation include Virology, Immunology, Drug resistance, Virus and Internal medicine. Lisa M. Frenkel interconnects Nevirapine, Antiretroviral therapy and Genotype in the investigation of issues within Virology. Her research investigates the connection with Immunology and areas like Acquired immunodeficiency syndrome which intersect with concerns in Pediatrics.
As a member of one scientific family, Lisa M. Frenkel mostly works in the field of Drug resistance, focusing on Molecular biology and, on occasion, Mutant. Her study in Randomized controlled trial is interdisciplinary in nature, drawing from both Placebo and Pre-exposure prophylaxis. Her work carried out in the field of Emtricitabine brings together such families of science as Gynecology and Serodiscordant.
Her primary areas of investigation include Virology, Drug resistance, HIV drug resistance, Antiretroviral therapy and Internal medicine. Her work in Viral replication and Virus is related to Virology. Her Drug resistance research is multidisciplinary, incorporating elements of Dolutegravir, Acquired immunodeficiency syndrome, Point mutation, Lamivudine and Resistance mutation.
In general Internal medicine, her work in Randomized controlled trial and Confidence interval is often linked to Minor linking many areas of study. Her biological study spans a wide range of topics, including Hazard ratio, Proportional hazards model and Emtricitabine. Her work deals with themes such as Open label, Gynecology, Gerontology and Serodiscordant, which intersect with Family medicine.
Lisa M. Frenkel mainly focuses on Drug resistance, Virology, Antiretroviral therapy, Internal medicine and HIV drug resistance. Her research on Drug resistance also deals with topics like
She combines subjects such as Proviral integration, Gene, Viral replication and Longevity with her study of Antiretroviral therapy. Her study focuses on the intersection of HIV drug resistance and fields such as Genotyping with connections in the field of Sanger sequencing, Medical physics and Virus. Lisa M. Frenkel focuses mostly in the field of Randomized controlled trial, narrowing it down to topics relating to Emtricitabine and, in certain cases, Pre-exposure prophylaxis, Bacterial vaginosis, Gardnerella vaginalis and Dysbiosis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Jared M. Baeten;Deborah Donnell;Deborah Donnell;Patrick Ndase;Nelly R. Mugo;Nelly R. Mugo.
The New England Journal of Medicine (2012)
Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection
Thor A. Wagner;Sherry McLaughlin;Sherry McLaughlin;Kavita Garg;Charles Y. K. Cheung.
Natural History of Neonatal Herpes Simplex Virus Infections in the Acyclovir Era
David W. Kimberlin;Chin-Yu Lin;Richard F. Jacobs;Dwight A. Powell.
A population-based study of primary human herpesvirus 6 infection.
Danielle M. Zerr;Amalia S. Meier;Stacy S. Selke;Lisa M. Frenkel.
The New England Journal of Medicine (2005)
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis
Ravindra K Gupta;John Gregson;Neil Parkin;Hiwot Haile-Selassie.
Lancet Infectious Diseases (2017)
Intravenous Immune Globulin for the Prevention of Bacterial Infections in Children with Symptomatic Human Immunodeficiency Virus Infection
A. Willoughby;L. M. Mofenson;R. Nugent;J. Moye.
The New England Journal of Medicine (1991)
Oral acyclovir suppression and neurodevelopment after neonatal herpes.
David W. Kimberlin;Richard J. Whitley;Wen Wan;Dwight A. Powell.
The New England Journal of Medicine (2011)
Evidence that Low-Level Viremias during Effective Highly Active Antiretroviral Therapy Result from Two Processes: Expression of Archival Virus and Replication of Virus
Nicole H. Tobin;Gerald H. Learn;Sarah E. Holte;Yang Wang.
Journal of Virology (2005)
Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022.
Jane Hitti;Lisa M. Frenkel;Alice M. Stek;Sharon A. Nachman.
Journal of Acquired Immune Deficiency Syndromes (2004)
Maternal Viral Genotypic Zidovudine Resistance and Infrequent Failure of Zidovudine Therapy to Prevent Perinatal Transmission of Human Immunodeficiency Virus Type 1 in Pediatric AIDS Clinical Trials Group Protocol 076
P. Scott Eastman;David E. Shapiro;Robert W. Coombs;Lisa M. Frenkel.
The Journal of Infectious Diseases (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: